SCHEMBL20705607

SCHEMBL20705607

CC1CCN(C2=NN3C(=N)/C(=C\c4ccc(SCC5CC(C6CCCCCCC6)CO5)o4)C(=O)N=C3S2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 16/20 0.47
KMT2A Q03164 16/20 0.47
POLB P06746 11/20 0.47
MAPT P10636 8/20 0.47
RECQL P46063 5/20 0.44
THRB P10828 3/20 0.44
BLM P54132 2/20 0.44
NSD2 O96028 2/20 0.44
ESR1 P03372 1/20 0.44
KDM4E B2RXH2 4/20 0.43
TDP1 Q9NUW8 4/20 0.43
ALDH1A1 P00352 3/20 0.43
PSMD14 O00487 2/20 0.43
MMP2 P08253 2/20 0.43
MCL1 Q07820 2/20 0.43
HPGD P15428 2/20 0.43
ESR2 Q92731 1/20 0.43
DNMT1 P26358 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13464887 0.65 KMT2A (0.55) MEN1KMT2APOLBMAPTTHRB
SCHEMBL22523765 0.55 SNRNP200 (0.88) MEN1KMT2APOLBMAPTRECQL
SCHEMBL12924181 0.44 SMN1; SMN2 (0.35) MEN1KMT2APOLBMAPTKDM4E
SCHEMBL13172821 0.41 ALDH1A1 (0.38) ALDH1A1
Biphenyl SCHEMBL28074752 0.41 ALDH1A1 (0.57) KMT2APOLBTDP1ALDH1A1
SCHEMBL5314209 0.41 ALDH1A1 (0.57) KMT2APOLBTDP1ALDH1A1
SCHEMBL10315999 0.41 L3MBTL3 (0.58) ALDH1A1L3MBTL1MAPK1CYP3A4CYP2C9
SCHEMBL26777511 0.41 KMT2A (0.44) MEN1KMT2APOLBMAPTKDM4E
SCHEMBL31058208 0.40 USP2 (0.41) POLBKDM4EALDH1A1HPGDCYP1A2
SCHEMBL22938022 0.40 ALDH1A1 (0.53) KMT2APOLBTDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10195213-B2 Chemical entities that kill senescent cells for use in treating age-related disease UNITY BIOTECHNOLOGY, INC. (US) 2019-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10195213-B2 Chemical entities that kill senescent cells for use in treating age-related disease TP53, CDKN1A, GLA MEN1 2434/4885KMT2A 2501/4885POLB 417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.